Clinical Trial Update: Oxaliplatin and S-1 or Oxaliplatin and Capecitabine in Treating Patients With Recurrent, Metastatic, or Unresectable Gastric Cancer [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating oxaliplatin with S-1 or with capecitabine in patients with recurrent, metastatic, or unresectabl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Yonsei University | Conditions: Gastric Cancer | Phase 2 | Status: UNKNOWN